Defective F9 variant does not activate FX
Lu Q, Yang L, Manithody C, Wang X, Rezaie AR. Expression and Characterization of Gly-317 Variants of Factor IX Causing Variable Bleeding in Hemophilia B Patients. Biochemistry. 2015 Jun 23;54(24):3814–21. PMID: 26023895; PMCID: PMC4479981.; Rallapalli PM, Kemball-Cook G, Tuddenham EG, Gomez K, Perkins SJ. An interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B. Journal of Thrombosis and Haemostasis. 2013 Jul;11(7):1329–40. doi: 10.1111/jth.12276.; Ludwig M, Sabharwal A, Brackmann H, Olek K, Smith K, Birktoft J, Bajaj S. Hemophilia B caused by five different nondeletion mutations in the protease domain of factor IX. 1992 Mar 01;79(5):1225–32. doi: 10.1182/blood.v79.5.1225.bloodjournal7951225.; Miyata T, Sakai T, Sugimoto M, Naka H, Yamamoto K, Yoshioka A, Fukui H, Mitsui K, Kamiya K, Umeyama H. Factor IX Amagasaki: a new mutation in the catalytic domain resulting in the loss of both coagulant and esterase activities. Biochemistry. 1991 Nov 26;30(47):11286–91. doi: 10.1021/bi00111a014. PMID: 1958666.; Hamaguchi N, Charifson PS, Pedersen LG, Brayer GD, Smith KJ, Stafford DW. Expression and characterization of human factor IX. Factor IXthr-397 and factor IXval-397. Journal of Biological Chemistry. 1991 Aug;266(23):15213–20. doi: 10.1016/s0021-9258(18)98605-9.; Bajaj SP, Spitzer SG, Welsh WJ, Warn-Cramer BJ, Kasper CK, Birktoft JJ. Experimental and theoretical evidence supporting the role of Gly363 in blood coagulation factor IXa (Gly193 in chymotrypsin) for proper activation of the proenzyme. Journal of Biological Chemistry. 1990 Feb;265(5):2956–61. doi: 10.1016/s0021-9258(19)39894-1.; Spitzer SG, Warn-Cramer BJ, Kasper CK, Bajaj SP. Replacement of isoleucine-397 by threonine in the clotting proteinase factor IXa (Los Angeles and Long Beach variants) affects macromolecular catalysis but not L-tosylarginine methyl ester hydrolysis. Lack of correlation between the ox brain prothrombin time and the mutation site in the variant proteins. Biochem J. 1990 Jan 01;265(1):219–25. PMID: 2105717; PMCID: PMC1136633.; Usharani P, Warn-Cramer BJ, Kasper CK, Bajaj SP. Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. Evidence for defects affecting the latent catalytic site. J Clin Invest. 1985 Jan;75(1):76–83. PMID: 3965513; PMCID: PMC423405.